Insiders who reported open-market trades in the last 12 months at the companies Anthony Welters files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
Johanna Mercier - $18.52M in GILD purchases and sales in the last 12 months
Deborah H. Telman - $6.59M in GILD purchases and sales in the last 12 months
Andrew D. Dickinson - $4.68M in GILD purchases and sales in the last 12 months
Jeffrey Bluestone - $1.35M in GILD purchases and sales in the last 12 months
Kelly A. Kramer - $713K in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Anthony Welters is a corporate insider, tracked as Director of GILEAD SCIENCES, INC. (GILD). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Anthony Welters submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Anthony Welters been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($2.77M) across all tracked filings.
Anthony Welters is Director of GILEAD SCIENCES, INC. (GILD). 8 SEC Form 4 filings on record going back to 2024, most recently on 27 August 2026. Most recent open-market trade: sold $1.02M of GILD on 27 August 2026. Lifetime open-market sales: $2.77M.
Recent transactions
16
The latest 16 SEC Form 4 transactions reported by Anthony Welters.
InsiderAlpha's records for Anthony Welters go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. 12 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
